Etretinate

• Description :

  Etretinate is a RAR and RXR agonist previoulsy used to treat psoriasis. It induces brth defects and suppresses proliferation in cutaneous T-cell lymphoma models.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  354.48

• Molecular Formula :

  C23H30O3

• Notes :

  Research use only, not for human use.

• Receptor :

  Others

• CAS Number :

  54350-48-0